Nordea Investment Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,810
Closed -$705K 990
2022
Q3
$705K Hold
2,810
﹤0.01% 846
2022
Q2
$701K Buy
2,810
+582
+26% +$157K ﹤0.01% 858
2022
Q1
$736K Sell
2,228
-16,027
-88% -$4.93M ﹤0.01% 849
2021
Q4
$6.58M Sell
18,255
-801
-4% -$271K 0.01% 527
2021
Q3
$6.35M Buy
19,056
+48
+0.3% +$16.3K 0.01% 560
2021
Q2
$5.93M Sell
19,008
-99
-0.5% -$30.4K 0.01% 575
2021
Q1
$6.11M Buy
19,107
+657
+4% +$210K 0.01% 535
2020
Q4
$5.98M Buy
18,450
+2,121
+13% +$587K 0.01% 491
2020
Q3
$4.47M Buy
16,329
+8,133
+99% +$2.34M 0.01% 512
2020
Q2
$1.96M Buy
8,196
+4,098
+100% +$823K ﹤0.01% 720
2020
Q1
$611K Sell
4,098
-5
-0.1% -$830 ﹤0.01% 766
2019
Q4
$701K Buy
4,103
+885
+28% +$164K ﹤0.01% 790
2019
Q3
$562K Buy
3,218
+123
+4% +$26.6K ﹤0.01% 830
2019
Q2
$807K Buy
3,095
+652
+27% +$173K ﹤0.01% 789
2019
Q1
$696K Buy
2,443
+459
+23% +$153K ﹤0.01% 1035
2018
Q4
$646K Buy
1,984
+69
+4% +$24K ﹤0.01% 1024
2018
Q3
$861K Hold
1,915
﹤0.01% 1026
2018
Q2
$783K Sell
1,915
-8,845
-82% -$3.2M ﹤0.01% 871
2018
Q1
$3.13M Sell
10,760
-2,127
-17% -$539K 0.01% 568
2017
Q4
$2.42M Sell
12,887
-1,630
-11% -$304K 0.01% 639
2017
Q3
$2.45M Buy
14,517
+502
+4% +$75.9K 0.01% 559
2017
Q2
$2.01M Sell
14,015
-194
-1% -$26.1K 0.01% 588
2017
Q1
$1.78M Buy
+14,209
New +$1.65M ﹤0.01% 583

Other funds holding ABMD

Nordea Investment Management's ABMD Position: Q4 2022 in Review

Nordea Investment Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,810 shares — an estimated $705K sold.

Nordea Investment Management first reported a position in ABMD in Q1 2017 and held it in 23 quarters. The position peaked at $6.58M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Nordea Investment Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Nordea Investment Management sold 2,810 Abiomed Inc shares in Q4 2022, an estimated $705K.
  • Nordea Investment Management first reported a position in Abiomed Inc in Q1 2017 and held it in 23 quarters.
  • Nordea Investment Management's Abiomed Inc position peaked at $6.58M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Nordea Investment Management's 13F filing for Q4 2022, filed 8 Feb 2023.